
FDA Approves Autologous Cellular Knee Implant
Vericel Corporation’s MACI autologous cellularized scaffold to repair articular cartilage defects has become the first implant of its kind to receive U.S. Food and Drug Administration approval. The approval was announced at the end of December 2016. Vericel’s MACI Knee Implant is comprised of an avascular sheet of the patient’s own cells which has grown […]
Jan 9, 2017

